Literature DB >> 16101007

Functional G protein-coupled receptor assays for primary and secondary screening.

Richard M Eglen1.   

Abstract

Screening technologies for G protein-coupled receptors comprise two major approaches; homogeneous assays, conducted in microtiter plate formats, and protein redistribution assays that require imaged-based analysis using automated confocal systems. Generally, the former are used in primary screening campaigns for lead identification, while the latter are used in secondary screens for lead optimization. Homogeneous assays measure changes in G protein-coupled receptor second messengers such as cAMP, Ins P3 or calcium. Protein redistribution assays assess internalization of the receptor ligand complex or translocation of G-protein coupled receptor-associated proteins, such as beta-arrestin. In the present review functional cell based approaches are discussed, emphasizing the variety of non radiometric technologies now in use for HTS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16101007     DOI: 10.2174/1386207054020813

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  9 in total

Review 1.  Probing heterotrimeric G protein activation: applications to biased ligands.

Authors:  Colette Denis; Aude Saulière; Segolene Galandrin; Jean-Michel Sénard; Céline Galés
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements.

Authors:  Ralf Schröder; Nicole Janssen; Johannes Schmidt; Anna Kebig; Nicole Merten; Stephanie Hennen; Anke Müller; Stefanie Blättermann; Marion Mohr-Andrä; Sabine Zahn; Jörg Wenzel; Nicola J Smith; Jesús Gomeza; Christel Drewke; Graeme Milligan; Klaus Mohr; Evi Kostenis
Journal:  Nat Biotechnol       Date:  2010-08-15       Impact factor: 54.908

3.  Discovery and validation of novel peptide agonists for G-protein-coupled receptors.

Authors:  Ronen Shemesh; Amir Toporik; Zurit Levine; Iris Hecht; Galit Rotman; Assaf Wool; Dvir Dahary; Eyal Gofer; Yossef Kliger; Michal Ayalon Soffer; Avi Rosenberg; Dani Eshel; Yossi Cohen
Journal:  J Biol Chem       Date:  2008-10-09       Impact factor: 5.157

4.  Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening.

Authors:  Shaun P Brothers; S Adrian Saldanha; Timothy P Spicer; Michael Cameron; Becky A Mercer; Peter Chase; Patricia McDonald; Claes Wahlestedt; Peter S Hodder
Journal:  Mol Pharmacol       Date:  2009-10-16       Impact factor: 4.436

5.  Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library.

Authors:  Seungkirl Ahn; Alem W Kahsai; Biswaranjan Pani; Qin-Ting Wang; Shuai Zhao; Alissa L Wall; Ryan T Strachan; Dean P Staus; Laura M Wingler; Lillian D Sun; Justine Sinnaeve; Minjung Choi; Ted Cho; Thomas T Xu; Gwenn M Hansen; Michael B Burnett; Jane E Lamerdin; Daniel L Bassoni; Bryant J Gavino; Gitte Husemoen; Eva K Olsen; Thomas Franch; Stefano Costanzi; Xin Chen; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-27       Impact factor: 11.205

6.  Investigating the ligand agonism and antagonism at the D2long receptor by dynamic mass redistribution.

Authors:  Lisa Forster; Steffen Pockes
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

7.  Imaging CXCR4 signaling with firefly luciferase complementation.

Authors:  Kathryn E Luker; Mudit Gupta; Gary D Luker
Journal:  Anal Chem       Date:  2008-06-06       Impact factor: 6.986

8.  Dielectric Spectroscopy Based Detection of Specific and Nonspecific Cellular Mechanisms.

Authors:  Michael R Stoneman; Valerică Raicu
Journal:  Sensors (Basel)       Date:  2021-05-03       Impact factor: 3.576

9.  Opioid doses required for pain management in lung cancer patients with different cholesterol levels: negative correlation between opioid doses and cholesterol levels.

Authors:  Zhenhua Huang; Lining Liang; Lingyu Li; Miao Xu; Xiang Li; Hao Sun; Songwei He; Lilong Lin; Yixin Zhang; Yancheng Song; Man Yang; Yuling Luo; Horace H Loh; Ping-Yee Law; Dayong Zheng; Hui Zheng
Journal:  Lipids Health Dis       Date:  2016-03-08       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.